Back
Bicycle Therapeutics PLC Stock Predictions
Former Zillow execs target $1.3T market
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
38
BCYC
Bicycle Therapeutics PLC
Last Price:
$8.33
Seasonality Move:
9.16%
7 Day Trial
ALL ACCESS PASS
$
7
Top investors are buying this "unlisted" stock
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.Bicycle Therapeutics PLC Stock Forecast
-
Over the next 52 weeks, Bicycle Therapeutics PLC has on average historically risen by 7.2% based on the past 5 years of stock performance.
-
Bicycle Therapeutics PLC has risen higher in 3 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
-
Is Bicycle Therapeutics PLC Stock Undervalued?The current Bicycle Therapeutics PLC [BCYC] share price is $8.34. The Score for BCYC is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
-
BCYC is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Bicycle Therapeutics PLC Stock Go Up Next Year?
-
Over the next 52 weeks, Bicycle Therapeutics PLC has on average historically risen by 7.2% based on the past 5 years of stock performance.
Bicycle Therapeutics PLC Stock Rating
Sell
38
Bicycle Therapeutics PLC (BCYC)
is a Sell
Is Bicycle Therapeutics PLC overpriced?
-
Bicycle Therapeutics PLC has risen higher in 3 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
Bicycle Therapeutics PLC Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United Kingdom
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
bicycletherapeutics.com
52-Week Data
52-Week High:
28.67
52-Week Low:
6.10
Prediction Charts
Market Cap:
577.6M
Price in USD:
8.34
Volume:
497.9K
Beta:
0.94
Technical Analysis
SMA50:
8.69
SMA100:
11.22
SMA200:
17.24
52-Wk Change:
-64.63%
Stock Predictions
-
Is Bicycle Therapeutics PLC stock public?Yes, Bicycle Therapeutics PLC is a publicly traded company.
-
What is the Bicycle Therapeutics PLC stock quote today?The Bicycle Therapeutics PLC stock price is 8.34 USD today.
-
How to buy Bicycle Therapeutics PLC stock online?You can buy Bicycle Therapeutics PLC shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Apr-22 | 7.61 | 8.73 | 8.90 | 7.61 |
| Apr-23 | 9.00 | 8.67 | 9.52 | 8.66 |
| Apr-24 | 8.63 | 8.60 | 8.92 | 8.26 |
| Apr-25 | 8.55 | 8.42 | 9.03 | 8.32 |
| Apr-28 | 8.39 | 8.40 | 8.79 | 8.22 |
| Apr-29 | 8.40 | 8.21 | 8.58 | 8.15 |
| Apr-30 | 8.50 | 8.56 | 8.67 | 7.95 |
| May-1 | 8.70 | 9.08 | 9.14 | 8.62 |
| May-2 | 9.44 | 9.30 | 9.55 | 9.13 |
| May-5 | 9.09 | 9.06 | 9.31 | 8.90 |
| May-6 | 9.03 | 7.40 | 9.08 | 7.39 |
| May-7 | 7.79 | 7.78 | 8.04 | 7.39 |
| May-8 | 7.77 | 8.18 | 8.27 | 7.51 |
| May-9 | 8.37 | 8.34 | 8.60 | 8.13 |
Bicycle Therapeutics PLC Earnings
Bicycle Therapeutics PLC Earnings Report: Per Share Bicycle Therapeutics PLC Earnings Q1 Q2 Q3 and Q4 last year and next year.
Bicycle Therapeutics PLC Forecast Revenue Growth
Bicycle Therapeutics PLC Stock Analysis: Historical quarterly revenues per share for Bicycle Therapeutics PLC and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.21 per share, a decrease next quarter of $0.11 per share, a decrease this year of $0.77 per share, and a decrease next year of $0.52 per share.
* Bicycle Therapeutics PLC stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.